We need to continue investing in research for early stage, localized prostate cancer, develop treatments that balance efficacy with quality-of-life considerations, ensure diverse representation in clinical trials, and listen to patients and incorporate their perspectives into treatment development and decision-making.
The post Prostate Cancer Management – We Need Better Options for Early-Stage Disease appeared first on MedCity News.
